These symptoms typically resolve as your body equilibrates to the medication, but persistent or severe chills warrant immediate contact with your prescribing provider
Injectable Dual Gut Peptide Agonists are Being Developed to Treat Obesity Tirzepatide Tirzepatide has recently been approved for long-term weight control in adults with obesity or overweight and at least one weight-related comorbidity
8,9 Spurred by recent approvals, the obesity market is expected to be worth over $100 billion by the end of the decade, up from $2.8 billion in 2022
The dysesthesia side effect Approximately 12.5% of participants on the highest dose of retatrutide experienced dysesthesia, or abnormal skin sensations, including a burning, tingling or pins and needles sensation
Online Doctor vs Endocrinologist for GLP-1: Who Should Prescribe
Fact: Stopping GLP-1 medications suddenly may contribute to increased appetite and rapid weight regain, so its important to work with a healthcare provider on a transition plan
